AI Article Synopsis
- The study assesses the efficacy of dynamic susceptibility contrast-enhanced (DSC) MRI parameters in differentiating between primary CNS lymphoma (PCNSL), glioblastoma, and metastasis in brain tumors.
- A cohort of 39 patients was analyzed, focusing on five DSC parameters: relative cerebral blood volume (rCBV), percentage of signal recovery (PSR), and others, to evaluate their diagnostic performance.
- Results indicated that rCBV was highly effective in distinguishing metastasis and glioblastoma from PCNSL, while PSR also showed significant differences, particularly identifying metastatic tumors compared to glioblastoma.
Article Abstract
Background And Purpose: Dynamic susceptibility contrast-enhanced (DSC) MR perfusion is a valuable technique for distinguishing brain tumors. Diagnostic potential of measurable parameters derived from preload leakage-corrected-DSC-MRI remains somewhat underexplored. This study aimed to evaluate these parameters for differentiating primary CNS lymphoma (PCNSL), glioblastoma, and metastasis.
Methods: Thirty-nine patients with pathologically proven PCNSL (n = 14), glioblastoma (n = 14), and metastasis (n = 11) were analyzed. Five DSC parameters-relative CBV (rCBV), percentage of signal recovery (PSR), downward slope (DS), upward slope (US), and first-pass slope ratio-were derived from tumor-enhancing areas. Diagnostic performance was assessed using receiver operating characteristic curve analysis.
Results: RCBV was higher in metastasis (4.58; interquartile range [IQR]: 2.54) and glioblastoma (3.98; IQR: 1.87), compared with PCNSL (1.46; IQR: 0.29; p = .00006 for both). rCBV better distinguished metastasis and glioblastoma from PCNSL, with an area under the curve (AUC) of 0.97 and 0.99, respectively. PSR was higher in PCNSL (88.11; IQR: 21.21) than metastases (58.30; IQR: 22.28; p = .0002), while glioblastoma (74.54; IQR: 21.23) presented almost significant trend-level differences compared to the others (p≈.05). AUCs were 0.79 (PCNSL vs. glioblastoma), 0.91 (PCNSL vs. metastasis), and 0.78 (glioblastoma vs. metastasis). DS and US parameters were statistically significant between glioblastoma (-109.92; IQR: 152.71 and 59.06; IQR: 52.87) and PCNSL (-47.36; IQR: 44.30 and 21.68; IQR: 16.85), presenting AUCs of 0.86 and 0.87.
Conclusion: Metastasis and glioblastoma can be better differentiated from PCNSL through rCBV. PSR demonstrated higher differential performance compared to the other parameters and seemed useful, allowing a proper distinction among all, particularly between metastasis and glioblastoma, where rCBV failed. Finally, DS and US were only helpful in differentiating glioblastoma from PCNSL.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/jon.13183 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mind Games: A Curious Case of Primary CNS Lymphoma Masquerading as Glioblastoma Multiforme.
Cureus
October 2024
Internal Medicine, Upstate University Hospital, Syracuse, USA.
The rare diffuse B-cell lymphoma subtype of primary central nervous system lymphomas (PCNSL) typically presents with nonspecific symptoms. Many of these symptoms overlap with those reported in cases of glioblastoma multiforme (GBM). However, despite the overlap in symptomatology, the two CNS tumors exhibit distinctly different imaging findings on MRI, which aids in diagnosis.
View Article and Find Full Text PDFReliable intraoperative diagnostic methods for PCNSL: utility of combining intraoperative immunohistochemistry, cytology, and flow cytometry in achieving optimal treatment.
Acta Neurol Belg
September 2024
Department of Neurosurgery, Ehime University School of Medicine, 454 Shitsukawa, Toon, Ehime, 791-0295, Japan.
Article Synopsis
- - The study focuses on improving the diagnosis of primary central nervous system lymphoma (PCNSL) during surgery by using intraoperative rapid immunohistochemistry (IHC), along with cytology and flow cytometry (FCM) for quicker and more accurate treatment decisions.
- - In a trial involving 35 patients from April 2020 to January 2024, the addition of cytology and FCM to rapid IHC significantly sped up the time from surgery to chemotherapy initiation for PCNSL (1.6 days versus 7.3 days), demonstrating the benefits of this combined approach.
- - Final pathological diagnoses confirmed the consistency of intraoperative rapid IHC results, and the combined method resulted in changes in treatment strategy in certain
Spectrum of [18F]FDG PET/CT Findings in Primary Central Nervous System Lymphoma - A Pictorial Essay.
Indian J Nucl Med
August 2024
Department of Nuclear Medicine, Sri Venkateswara Institute of Medical Sciences, Tirupati, Andhra Pradesh, India.
Primary central nervous system lymphoma (PCNSL) is a rare, aggressive variant of extranodal non-Hodgkin's lymphoma. Although gadolinium-enhanced magnetic resonance imaging remains the initial imaging modality of choice, a whole-body F-18 fluorodeoxyglucose (FDG) positron emission tomography-computed tomography is imperative to exclude systemic lymphomatous involvement. Furthermore, the metabolic parameter, maximum standardized uptake value (SUV) of the lesion, tumor-to-normal cerebral tissue SUV ratio, and FDG uptake patterns help in differentiating intracranial lymphomas from High-grade Glioblastoma Multiforme (HGM) and infectious lesions, and hence, consolidating the diagnosis.
View Article and Find Full Text PDF"Synthetic" DSC perfusion MRI with adjustable acquisition parameters in brain tumors using dynamic spin-and-gradient-echo echoplanar imaging.
AJNR Am J Neuroradiol
September 2024
From the UCLA Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, and Department of Radiological Sciences, (F.S., J.Y., N.S.C., C.R., B.M.E.), Department of Neurosurgery (R.G.E., B.M.E.), Department of Neurology (T.F.C.), Department of Radiological Sciences (W.B.P., N.S.), Department of Psychiatry and Biobehavioral Sciences (B.M.E.), Medical Scientist Training Program (N.S.C.), David Geffen School of Medicine, Department of Bioengineering, Henry Samueli School of Engineering and Applied Science (N.S.C., B.M.E.), Department of Biostatistics (D.T.), University of California Los Angeles, Los Angeles, CA, USA; from the Department of Diagnostic Imaging (J.L.B.), Warren Alpert Medical School, Brown University, Providence, RI, USA.
Background And Purpose: Normalized relative cerebral blood volume (nrCBV) and percentage of signal recovery (PSR) computed from dynamic susceptibility contrast (DSC) perfusion imaging are useful biomarkers for differential diagnosis and treatment response assessment in brain tumors. However, their measurements are dependent on DSC acquisition factors, and CBV-optimized protocols technically differ from PSR-optimized protocols. This study aimed to generate "synthetic" DSC data with adjustable synthetic acquisition parameters using dual-echo gradient-echo (GE) DSC datasets extracted from dynamic spin-and-gradient-echo echoplanar imaging (dynamic SAGE-EPI).
View Article and Find Full Text PDFMulticenter investigation of preoperative distinction between primary central nervous system lymphomas and glioblastomas through interpretable artificial intelligence models.
Neuroradiology
November 2024
Laboratory for Medical Imaging Informatics, Shanghai Institute of Technical Physics, Chinese Academy of Sciences, Shanghai, 200083, China.
Objective: Research into the effectiveness and applicability of deep learning, radiomics, and their integrated models based on Magnetic Resonance Imaging (MRI) for preoperative differentiation between Primary Central Nervous System Lymphoma (PCNSL) and Glioblastoma (GBM), along with an exploration of the interpretability of these models.
Materials And Methods: A retrospective analysis was performed on MRI images and clinical data from 261 patients across two medical centers. The data were split into a training set (n = 153, medical center 1) and an external test set (n = 108, medical center 2).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!